Scott Holmstrom, Ph. D.

Chief Executive Officer

  • Expertise: Leadership | Animal Health | Drug Development | Business Development | Regulatory Affairs

  • Strategic forward thinking CEO with over 20+ years in the animal health, human health pharma, and biotech industries as part of a multi-billion dollar Fortune 1000 company.

  • Known for significant scientific research and leadership driving drug development and innovation regulatory, securing robust intellectual property, and leading business units to prioritize and commercialize cutting-edge drug products.

  • Recognized for innovative leadership over multi-cultural and multi-functional teams, ensuring talent is optimized with mentoring and coaching, while delivering exemplary execution of drug development, regulatory strategy, intellectual property, and global marketing plans.

  • Expanded global markets with novel products, educated key opinion leaders and customers on latest developments, and drove cross-functional process improvement projects with successful outcomes for division and organization.

  • EXECUTIVE CAREER MILESTONES

  • 2022: Lead In the Bowl Animal Health as CEO; Venture Partner with Mountain Group Partners

  • 2022: Led the Series Seed A Financing for Genvax Technology for United Animal Health

  • 2021: Led the R&D, technical services, regulatory affairs, and external innovation for United Animal Health as Senior Vice President, R&D

  • 2021: Established externally funded research and development (R&D) partnership. 2020, Research & Development and regulatory integration lead for Prevtec Microbia and Aratana Therapeutics. 2020, Globally led US and EU R&D antitrust efforts enabling $7.6B acquisition of Bayer Animal Health.

  • 2019: Led research and development and intellectual property due diligence for $7.6B acquisition of Bayer Animal Health.

  • 2016: Business lead for global Galliprant license with Aratana Therapeutics

  • 2015: Developed breakthrough regulatory strategy with FDA and EMA for Imrestor, a key biotech product.

  • 2014: Invited by U.S. Government, served on the Joint WHO-FAO Codex Commission to implement food safety standards.

  • 2006-11: Led global development and registration of Comfortis and Trifexis with an amazing team that has produced more than $3B revenue.

  • 2012-2014: Spearheaded multiple risk share discovery programs, from conception to patent to projects.

  • 2011: Integrating R&D and regulatory from Janssen Animal Health with sustained working relationships and friendships.

Ph.D. in Analytical Chemistry from Miami University